- Home
- PSTV vs CLDI Comparison
PSTV vs CLDI Comparison
Compare PSTV & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- CLDI
- Stock Information
- Founded
- PSTV 1996
- CLDI 2014
- Country
- PSTV United States
- CLDI United States
- Employees
- PSTV N/A
- CLDI N/A
- Industry
- PSTV Medical/Dental Instruments
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PSTV Health Care
- CLDI Health Care
- Exchange
- PSTV Nasdaq
- CLDI Nasdaq
- Market Cap
- PSTV 10.4M
- CLDI 10.2M
- IPO Year
- PSTV N/A
- CLDI N/A
- Fundamental
- Price
- PSTV $0.18
- CLDI $0.29
- Analyst Decision
- PSTV Strong Buy
- CLDI Strong Buy
- Analyst Count
- PSTV 3
- CLDI 1
- Target Price
- PSTV $13.00
- CLDI $10.00
- AVG Volume (30 Days)
- PSTV 13.6M
- CLDI 684.1K
- Earning Date
- PSTV 08-13-2025
- CLDI 08-12-2025
- Dividend Yield
- PSTV N/A
- CLDI N/A
- EPS Growth
- PSTV N/A
- CLDI N/A
- EPS
- PSTV N/A
- CLDI N/A
- Revenue
- PSTV $5,206,000.00
- CLDI N/A
- Revenue This Year
- PSTV $13.26
- CLDI N/A
- Revenue Next Year
- PSTV $8.84
- CLDI N/A
- P/E Ratio
- PSTV N/A
- CLDI N/A
- Revenue Growth
- PSTV N/A
- CLDI N/A
- 52 Week Low
- PSTV $0.16
- CLDI $0.27
- 52 Week High
- PSTV $2.31
- CLDI $3.89
- Technical
- Relative Strength Index (RSI)
- PSTV 29.61
- CLDI 28.18
- Support Level
- PSTV $0.16
- CLDI $0.31
- Resistance Level
- PSTV $0.36
- CLDI $0.35
- Average True Range (ATR)
- PSTV 0.04
- CLDI 0.04
- MACD
- PSTV -0.00
- CLDI -0.00
- Stochastic Oscillator
- PSTV 8.38
- CLDI 13.60
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.